Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

ClubMed Lifestyle Group / Equity Capital Markets

<ul>
<li>ClubMed, a premium all-inclusive resort operator, has filed its prospectus with the HKEX. BNP Paribas, HSBC, and JPM are the joint sponsors.</li>
<li>We look at the company's core segments: Club Med resort operations and vacation scenario services.</li>
<li>We then look at the company's financial profile, profit decline, ownership structure and pre-IPO backing.</li>
</ul>


ClubMed, a premium all-inclusive resort operator, has filed its prospectus with the HKEX. BNP Paribas, HSBC, and JPM are the joint sponsors.
We look at the company's core segments: Club Med resort operations and vacation scenario services.
We then look at the company's financial profile, profit decline, ownership structure and pre-IPO backing.


ClubMed Lifestyle Group

ClubMed Pre-IPO: Tearsheet